Arcadis reports transactions under its current share buyback program
20 January 2021 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, has repurchased 136,689 of its own shares in the period from 13 January 2021 up to and including 19 January 2021 at an average price of €29.61. The consideration of this repurchase was €4.0 million. The repurchase is in accordance with the share buyback program to cover obligations from employee incentive plans, as announced on 30 December 2020.
The total number of shares repurchased under this program to date is 270,598 shares for a total consideration of €7.9 million.
For more detailed information see: https://www.arcadis.com/en/global/investors/share-information/share-buyback-program/
For further information please contact:
Arcadis Investor Relations
Mobile: +31 6 51599483
Arcadis is a leading global Design & Consultancy organization for natural and built assets. Applying our deep market sector insights and collective design, consultancy, engineering, project and management services we work in partnership with our clients to deliver exceptional and sustainable outcomes throughout the lifecycle of their natural and built assets. We are 28,000 people, active in over 70 countries that generate €3.5 billion in revenues. We support UN-Habitat with knowledge and expertise to improve the quality of life in rapidly growing cities around the world. www.arcadis.com .
This press release contains information that qualifies or may qualify as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
- Arcadis reports transactions under its current share buyback program week 3
- 2021 Arcadis Share Buyback program
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
iRemedy8.3.2021 14:31:30 CET | Press release
iRemedy Procures Supply of 500 Million More Low-Dead Space Syringes and Needles in Support of "Project Vaccinate"
Nexstim Oyj8.3.2021 14:16:29 CET | Press release
Nexstim Plc publishes an EU growth prospectus regarding EUR 6.6 million subscription rights issue
Ringkjøbing Landbobank A/S8.3.2021 14:04:28 CET | Press release
Articles of Association for Ringkjøbing Landbobank A/S
Ringkjøbing Landbobank A/S8.3.2021 14:04:18 CET | Pressemeddelelse
Vedtægter for Ringkjøbing Landbobank A/S
Harder LLP8.3.2021 14:01:48 CET | Press release
Famed Attorney CHARLES HARDER Releases Book GAWKER SLAYER on Fifth Anniversary of $140 Million Trial Victory For Hulk Hogan Against Gawker Media
Merus N.V.8.3.2021 14:01:37 CET | Press release
Merus to Participate in a Fireside Chat at the 33rd Annual Roth Conference
Saniona AB8.3.2021 14:01:26 CET | Press release
Saniona Receives Feedback from U.S. FDA Providing a Regulatory Path Forward for Tesomet in Hypothalamic Obesity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom